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ABSTRACT 
Objective:  The aim of the current study was to define the outcome of the Craniopharyngioma by available 
multiple treatment options. 
Material and Methods:  A Retrospective study was Neurospinal and Cancer Care Institute Karachi. A total of 
81 consecutive patients who underwent treatment were included. Information regarding the treatment parameters 
like volume, prescribed dose, maximum dose was noted along with the baseline characteristics like age and 
gender of the patients. The 24-months survival was also observed in these patients after stereo tactically reservoir 
placement, aspiration and Gamma knife radiosurgery. 
Results:  The median age was 18 (IQR: 12-33) years. The median volume, prescription dose and maximum dose 
was 9.2 (IQR: 5.35-17.40) ml, 12 (IQR: 10-12) Gy, and 24 (IQR: 22-26) Gy respectively. 24-months follow-up 
showed that complete response was observed in 59 (72.8%), mild to moderate reduction in 20 (24.7%) whereas 
mortality in 2 (2.5%) patients. Amongst the two patients in whom mortality was observed, one patient had 
increased the size of tumor, whereas another patient showed a static tumor in size. The overall survival rate was 
97.5%. 
Conclusion:  Craniopharyngioma is a tumor can be managed by multiple treatment options dueto its presentation 
and attachments. The multimodality management is associated with improved tumor control with acceptable 
complications. 
Keywords:  Craniopharyngioma, Ommaya Reservoir, Stereotactic, Gama Knife Radiosurgery Surgery. 
 
INTRODUCTION 
The ideal management of Craniopharyngioma (CP) is 
challenging due to their location, it’s a slow growing 
benign tumor. The emergence of CPs is observed from 
Rathke’s cleft or craniopharyngeal duct.1 Between the 
age group, these tumors occur children and adults with 
a bimodal age distribution.2 The location of these 
tumors is considered with pituitary stalk, visual 
apparatus, vasculature from the Willis circle and 3rd 
ventricle.3 In selected patients, gross total resection 
(GTR) deemed to be effective about the local tumor 
control as compared to subtotal resection. Thereby, the 
mainstay therapeutic approach is represented by GTR.4 
The purpose GTR can be complex to achieve due to 
the intimate correlation between the neural and 
vascular structures and tumor, regardless of any 
endocrine, surgery-related visual and neurologic 
complications.5 
 High operative mortality and morbidity implies 
formidable difficulties in order to treat these tumors, 
although the progression in endoscopic and 
microsurgical techniques offer better surgical 
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outcomes to neurosurgeons in the form of success rate 
and the GTR rate of repeat surgeries.6 
 The use of Gamma Knife surgery (GKS) has been 
demonstrated recently for residual or recurrent 
Craniopharyngioma associated with local progression 
or tumor control free survival. It has been used 
increasingly for treating recurrent or residual 
Craniopharyngioma by zero mortality and lower 
morbidity.7 
 The study intended to determine progression free 
survival among Craniopharyngioma patients treated 
with multiple available options as cystic aspiration and 
GKS. This would be its kind of study from Pakistan to 
report the outcome of Craniopharyngioma patients 
treated with multiple treatment option including 
gamma knife surgery as an in-depth literature. 
 
MATERIALS AND METHODS 
Study Design 
Retrospective analytic study. This study was 
conducted at the Neurospinal and Cancer Care 
Institute, Karachi, Pakistan from June 2012 and 
January 2018. A total of 81 consecutive patients who 
underwent treatment were included. 
 
Inclusion Criteria 
The age above 5 years, clinical and imaging favoring 
the diagnosis of Craniopharyngioma having cystic and 
sold component on imaging. 
 
Exclusion Criteria 
Age less than 5 years, previously operated cases, 
recurrent cases. 
 
Surgical Technique 
Gamma knife technique in adults was performed using 
a Leksell frame which was placed under local 
anesthesia exceptionwas considered for the GKS 
procedure in pediatric patients,especially under the age 
of 14 for placement of the frame was done under 
general anesthesia, which was retained during the 
GKS procedure. Thereafter, MRI brain was donewith a 
stereotactic frame to proceeds further treatment plans. 
When due to implants or other reason MRI was not 
possible, CT scan brain was choice for target selection. 
The main purpose of planning the dosage in GKS for 
Craniopharyngioma was to maximize the effect in the 
solid portion of the tumor without causing irradiation 
of the surrounding normal brain structure or with 
minimal effect especially deep structures which were 
sensitive to radiation notable structure were 
hypothalamus, brainstem, optical apparatus and 
thalamus. When the optical apparatus was in close 
range to Craniopharyngioma was treated with lower 
doses, resulting in a maximum dose of less than 12 Gy 
for the visual pathway structures. Cystic components 
were treated on the same day or a few days before with 
stereotactic aspiration followed by radiosurgery. 
 
Follow-up 
After GKS, all patients underwent on average 24-
months intervals of clinical evaluations. 
 Information regarding the treatment parameters 
like volume, prescribed dose and maximum dose were 
noted along with the baseline characteristics like age 
and gender of the patients. The 24-months survival 
was also observed in these patients after aspiration and 
reservoir placement stereotactically and Gamma knife 
radiosurgery. 
 
Data Analysis 
Statistical analysis for Social Sciences (SPSS) version 
22 was used for the purpose of statistical analysis. 
Median and interquartile ranges were reported for 
quantitative variables like age and treatment 
parameters like volume, prescribed dose and 
maximum dose. Frequency and percentages were 
calculated for quantitative variables like gender, 
complete response, and 12-months survival. Statistical 
analysis was carried out using Mann-Whitney U test 
and chi-square test. P-value < 0.05 was taken as 
significant. 
 
RESULTS 
Out of total 81 patients, the median age was 18 
(interquartile range-IQR: 12-33) years, while 
minimum age was five years and maximum age was 
53 years. There were 60 (74.1%) males and the 
remaining 21 (25.9%) were females. The median 
volume of the Craniopharyngioma was 9.2 (IQR: 5.35-
17.40) ml; ranges from 0.98 ml as the minimum and 
57.40 as the maximum. The median prescription dose 
was 12 (IQR: 10-12); ranges from 1 as the minimum 
and 23 as the maximum. The maximum dose was 24 
(IQR: 22-26). 
 All patients were clinically followed-up by 
neuroimaging, complete response was observed in 59 
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Fig. 1: Survival Curve Demonstrating Overall Survival 
Following GKS. 
 
(72.8%), mild to moderate reduction in 20 (24.7%) 
whereas mortality in 2 (2.5%) patients. Amongst the 
two patients in whom mortality was observed, one 
patient had increased the size of the tumor, whereas 
another patient showed a static tumor in size. The 
overall survival rate was 97.5% (Figure 1). 
 The comparison of treatment parameters of 
Craniopharyngioma patients with age and gender has 
showed significant difference of maximum dose with 
age (p-value 0.014) only (Table 1). 
 An insignificant association of gamma knife 
surgery was observed with prognostic factors like age 
(p-value 0.117), gender (0.191), volume (p-value 
0.767), prescribed dose (p-value 0.494) and maximum 
dose (p-value 0.168 (Table 2). 
Table 1: Comparison of Treatment Parameters of Craniopharyngioma 
 Patients with Age and Gender. 
 
   Volume, ml   Prescribed Dose, Gy   Maximum Dose, Gy 
Total (n = 81) 9.2 (5.4 – 17.4) 12 (10-12) 24 (22-26) 
Age, Years 
≤ 18 (n = 41) 10.2 (6.2 – 17.4) 12.0 (10.0-12.0) 24 (20-24) 
> 18 (n = 40) 8.1 (4.7 – 18.5) 12.2 (10.0-13.0) 24 (24-27) 
p-value 0.527 0.109 0.014* 
Gender 
Male (n = 60) 13.4 (5.0 – 17.7) 12 (10.0-12.0) 24 (22.1-25.8) 
Female (n = 21) 8.5 (6.5 – 17.8) 12 (10-13.5) 24 (22.5-28.0) 
p-value 0.901 0.340 0.578 
 
All data presented as median (IQR), Mann-Whitney u test applied, p-value < 0.05 taken 
as significant, *significant 
 
Table 2: Comparison of Outcome of GKS among 
Craniopharyngioma Patients with Prognostic 
Factors. 
 
Variables 
Total 
Complete Response 
Yes No p-
value n (%) n (%) 
Age, years 
≤ 18 41 33 (81)   8 (20) 
0.117 
> 18 40 26 (65) 14 (35) 
Gender 
Male 60 46 (77) 14 (23) 
0.191 
Female 21 13 (62) 8 (38) 
Volume, ml 
≤ 19 39 29 (74) 10 (26) 
0.767 
> 19 42 30 (71) 12 (29) 
Prescribed Dose, Gy 
≤ 12 62 44 (71) 18 (29) 0.494 
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> 12 19 15 (79)   4 (21) 
Maximum Dose, Gy 
≤ 24 57 39 (68) 18 (32) 
0.168 
> 24 24 20 (83) 4 (17) 
 
 
 
Fig. 2: CT Brain showing that Ommaya Reservoir in Cystic 
Portion. 
 
 
 
Fig. 3: Result of Craniopharyngioma after One-Year 
Follow-up. 
 
 
 
Fig. 4: MRI Brain Axial View Showing Ommaya Reservoir 
in Situ. 
 
DISCUSSION 
This study was conducted at neurospinal and cancer 
care institutes with Gamma knife and Stereotactic 
placement of the reservoir.In the current study, 
multiple modality options used to improve progression 
free survival among Craniopharyngiomas patients 
treated with GKS were studied. Previously, several 
studies have reported the use of Gamma Knife surgery 
among Craniopharyngioma patients.8-10 The outcome 
of the study has showed a satisfactory response in the 
majority of the patients while mortality was observed 
in only 2 patients. Although this finding matched with 
a previous study of Bishop et al in which progression 
free survival was observed in almost 92% of the 
patients.11 The only difference observed was that the 
follow-up in the current study was 2 years. However, 
in the study of Bishop et al, five-year survival was 
reported. A 10-year survival rate of 91% was also 
reported in a study by Kobayashi et al,12 Control was 
seen in 90%, 80% and 59% solid, cystic and in mixed 
tumors, respectively, with a mortality of 0.5% 
conducted by Gopalan et al,13 while in this study, 94% 
control was observed. 
 In the current study, of 2 patients in whom 
mortality was observed, 1 patient had increased the 
size of the tumor, whereas another patient showed a 
static tumor in size. In a previous study, mortality was 
reported in almost 9% patients. 
 The literature review revealed Craniopharyngioma 
series of differences in progression-free survival and 
overall survivalrates based on the different 
radiosurgical images. In the study, the overall 5-year 
survival was 75.5 percent and progression free 
survival rates was 67 percent14. Hasegawa et al. 
reported a 5-and 10-year progression of free survival 
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rates of 62 per cent and 52 per cent respectively 15. 
Niranjan et al. reported a total 5-year survival rate of 
97.5 percent and a 5-year progression-free survival 
rate of 91.6 percent.16 
 In the current study, the median prescription dose 
was 12 whereas the maximum dose was 24. Various 
studies have reported that a dose of 12 Gy may be 
adequate for tumor control,12,17 and the dose to the 
optic apparatus in the vicinity should not exceed 8 Gy. 
A highly conformal plan should be tailored to 
minimize dosing to the optic apparatus, using smaller 
radiation doses. Cystic enlargement of 
Craniopharyngioma can occur after gamma knife 
surgery, leading to visual deterioration,18 which may 
require aspiration of the cyst for immediate relief. In 
the study of Kobayashi et al.12 the prescribed dose was 
11.5 Gy. 
 The results of the study were also corroborated 
with the findings of other studies that revealed a strong 
association between marginal dose to the tumor and 
effect of GKS.9,10,19,20 Tumor volume and proximity to 
vital structures are the factors that rely on the selection 
of marginal dose. Generally, the effective 
consequences were attained with marginal cystic 
aspiration resulting in decrease volume, followed by 
GKS. Paucity of VFG can be interpreted as that tumor 
was not reachable due to the substantial decrease from 
an appropriate decompression in tumor size.9,21 
Therefore; it allows an increase of marginal quantity to 
the solid component of the tumor, which results in an 
expanded in-field program for studies. 
 The finding of our study could be highlighted in 
the light of the limitation that the sample size was 
smaller and shorter follow-up period. Therefore, our 
data should be extrapolated to generalize the findings 
by undertaking larger sample size. Also, future studies 
should include hospital stays, patient’s activity level, 
and quality of life as to be examined for the specific 
disease through the treatment used. 
 Because the Craniopharyngioma is a benign tumor 
and varied mode of presentation in both adults and in 
children; the treatment options of patients having such 
variable tumor are diverse and surgical treatment 
options range from aspiration of cystic contents and 
placement of the Ommaya reservoir to craniotomy and 
complete excision or partial debulking to 
chemotherapy or radiotherapy or radiosurgery. This 
tumor is more complicated and complex in its clinical 
presentation and position and in its connection to the 
medical and sensitive systems around it. 
CONCLUSION 
The current study suggests that Craniopharyngioma is 
a tumor that must be managed by multiple treatment 
options; initially debulk decrease pressure effects on 
the surrounding critical vital structures by aspiration of 
cystic contents and Ommaya reservoir placement 
followed by Gamma Knife radiosurgery. This 
multimodality management is associated with 
improved tumor control with acceptable 
complications. 
 
REFERENCES 
1. Himes BT, Ruff MW, Van Gompel JJ, Park SS, Galanis 
E, Kaufmann TJ, Uhm JH. Recurrent papillary 
craniopharyngioma with BRAF V600E mutation 
treated with dabrafenib: case report. Journal of 
Neurosurgery, 2018; 130 (4): 1299-303. 
2. Chu C, Su Y, Lieu A, Lin C, Kwan A. Comparison 
Study of Clinical Presentation and Surgical Outcome 
between Children and Adults with Craniopharyngioma: 
A 22-Year Single-Center Experience in Southern 
Taiwan. J Neurol Disord. 2017; 5 (350): 2. 
3. Attuati L, Picozzi P. Radiotherapy and Radiosurgery 
for Craniopharyngiomas. In Diagnosis and 
Management of Craniopharyngiomas, 2016: (pp. 101-
112). Springer, Cham. 
4. Kobayashi T, Tsugawa T, Hatano M, Hashizume C, 
Mori Y, Shibamoto Y. Gamma knife radiosurgery of 
craniopharyngioma: results of 30 cases treated at 
Nagoya Radiosurgery Center. Nagoya Journal of 
Medical Science, 2015; 77 (3): 447. 
5. Müller HL. Craniopharyngioma and hypothalamic 
injury: latest insights into consequent eating disorders 
and obesity. Current Opinion in Endocrinology, 
Diabetes, and Obesity, 2016; 23 (1): 81. 
6. Lania A, Spada A, Lasio G. Diagnosis and management 
of craniopharyngiomas. Springer International 
Publishing, 2016. 
7. Lubuulwa J, Miao Z, Liu S, Chen J, Wang S, Jiang W, 
Shu K, Lei T. Clinical, Pathological and Surgical Risk 
Factors Associated with Craniopharyngioma 
Recurrence: A Literature Review. Neurosurgery, 2019; 
9: 61-77. 
8. Muskens IS, Najafabadi AH, Briceno V, Lamba N, 
Senders JT, van Furth WR, Verstegen MJ, Smith TR, 
Mekary RA, Eenhorst CA, Broekman ML. Visual 
outcomes after endoscopic endonasal pituitary adenoma 
resection: a systematic review and meta-analysis. 
Pituitary, 2017; 20 (5): 539-52. 
9. Dho YS, Kim YH, Kim JW, Park CK, Chung HT, Kim 
SK, Paek SH, Wang KC, Kim DG. Optimal strategy of 
gamma knife radiosurgery for craniopharyngiomas. 
Journal of Neuro-Oncology, 2018; 140 (1): 135-43. 
Aurangzeb Kalhoro, et al 
-107-         Pak. J. of Neurol. Surg. – Vol. 24, No. 2, Apr. – Jun., 2020         http//www.pakjns.org 
10. Losa M, Pieri V, Bailo M, Gagliardi F, Barzaghi LR, 
Gioia L, Del Vecchio A, Bolognesi A, Mortini P. 
Single fraction and multisession Gamma Knife 
radiosurgery for craniopharyngioma. Pituitary, 2018; 21 
(5): 499-506. 
11. Bishop AJ, Grosshans DR. Craniopharyngioma. 
InRadiation Oncology for Pediatric CNS Tumors, 2018: 
pp. 295-309. Springer, Cham. 
12. Kobayashi T, Kida Y, Mori Y, Hasegawa T. Long-term 
results of gamma knife surgery in the treatment of 
craniopharyngioma in 98 consecutive cases. J 
Neurosurg. 2005; 103 (6 Suppl): 482-8. 
13. Gopalan R, Dassoulas K, Rainey J, Sherman JH, 
Sheehan JP. Evaluation of the role of Gamma Knife 
surgery in the treatment of craniopharyngiomas. 
Neurosurgical Focus, 2008; 24 (5): E5. 
14. Xu Z, Yen CP, Schlesinger D, Sheehan J: Outcomes of 
Gamma Knife surgery for craniopharyngiomas. J 
Neurooncol. 2011; 104: 305–313. 
15. Hasegawa T, Kobayashi T, Kida Y: Tolerance of the 
optic apparatus in single-fraction irradiation using 
stereotactic radiosurgery: evaluation in 100 patients 
with craniopharyngioma. Neurosurgery, 2010; 66: 688–
695. 
16. Niranjan A, Kano H, Mathieu D, Kondziolka D, 
Flickinger JC, Lunsford LD: Radiosurgery for 
craniopharyngioma. Int J Radiat Oncol Biol Phys. 
2010; 78: 64–71. 
17. Ulfarsson E, Lindquist E, Roberts M, Rähn T, Lindquist 
M, Thorén M, et al. Gamma Knife radiosurgery for 
craniopharyngiomas: Long-term results in the first 
Swedish patients. J Neurosurg. 2002; 97 (5 Suppl): 613-
22. 
18. Chung WY, Pan DH, Shiau CY, Guo WY, Wang LW. 
Gamma knife radiosurgery for craniopharyngiomas. J 
Neurosurg. 2000; 93 (3 Suppl): 47-56. 
19. Juloori A, Murphy ES. Pediatric Radiosurgery. In 
Stereotactic Radiosurgery and Stereotactic Body 
Radiation Therapy, 2019: 331-343. Springer, Cham. 
20. Saleem MA, Hashim AS, Rashid A, Ali M. Role of 
gamma knife radiosurgery in multimodality 
management of craniopharyngioma. InGamma Knife 
Neurosurgery in the Management of Intracranial 
Disorders, 2013: 55-60. Springer, Vienna. 
21. Mortini P, Gagliardi F, Bailo M, Losa M. Surgical 
Approach to Craniopharyngiomas: Transcranial Routes. 
In Diagnosis and Management of Craniopharyngiomas, 
2016: 85-99. Springer, Cham. 
 
 
 
Additional Information 
Disclosures: Authors report no conflict of interest. 
EthicalReview Board Approval: The study was conformed to the ethical review board requirements. 
Human Subjects: Consent was obtained by all patients/participants in this study. 
Conflicts of Interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following. 
Financial Relationships: All authors have declared that they have no financial relationships at present or within the previous 
three years with any organizations that might have an interest in the submitted work. 
Other Relationships: All authors have declared that there are no other relationships or activities that could appear to have 
influenced the submitted work. 
 
 
 
Address for Correspondence: Aurangzeb Kalhoro 
Department of Neurosurgery, Jinnah Medical Dental College, Karachi 
draurangzebkalhoro@gmail.com       
 
AUTHORSHIP AND CONTRIBUTION DECLARATION 
 
 
Sr.# 
Author’s Full Name and 
Affiliation 
Intellectual Contribution to Paper in Terms of: 
1. Aurangzeb Kalhoro 
Study design and methodology. 
Proposed topics and Basic Study Design, & data collection statistical analysis 
Data collection and calculations 
2. Sanam B Rajper Referencing, data calculations and manuscript writing 
3. Abid Saleem Analysis of data and interpretation of results etc. 
4. Abdul Sattar M. Hashim Analysis of data  and quality insurer Literature review 
 
Date of Submission: 17-2-2020 
Date of Revision: 16-05-2020 
Date of Online Publishing: 30-06-2020 
Date of Print: 30-07-2020 
